Kristine Alexander
About Kristine Alexander
Kristine Alexander is a Medical Policy Research Analyst at Cambia Health Solutions, where she has worked since 2016. She has a strong background in genetics and medical policy, having previously held positions at the National Institutes of Health and Oregon Health & Science University.
Work at Cambia Health Solutions
Kristine Alexander has been employed at Cambia Health Solutions as a Medical Policy Research Analyst since 2016. In this role, she focuses on analyzing medical policies and their implications for healthcare practices. Her work involves evaluating clinical risks and benefits associated with genetic testing, contributing to informed decision-making within the organization. Cambia Health Solutions operates in the healthcare sector, emphasizing innovative solutions and evidence-based practices.
Previous Experience at National Institutes of Health
Before joining Cambia Health Solutions, Kristine Alexander worked at the National Institutes of Health (NIH) as a Health Science Policy Analyst. She served in this capacity for one year, from 2015 to 2016, in Bethesda, Maryland. During her tenure at NIH, she contributed to health science policy development, leveraging her expertise in genetics and clinical research.
Background in Research and Academia
Kristine Alexander has an extensive background in research and academia. She served as a Graduate Research Assistant at Oregon Health & Science University from 2005 to 2012, where she engaged in various research projects. Following this, she was a Postdoctoral Fellow at the University of Vermont from 2012 to 2015, working under Dr. Mary Cushman. Her academic journey has equipped her with a strong foundation in genetics, clinical research, and epidemiology.
Education and Expertise
Kristine Alexander earned her PhD and Master of Clinical Research (MCR) from Oregon Health & Science University, where she studied from 2005 to 2012. Prior to this, she completed her Bachelor of Science (BS) in Cell/Cellular and Molecular Biology at Western Washington University from 2003 to 2005. Her educational background supports her specialization in analyzing clinical risks and benefits related to genetic testing and her passion for evidence-based medicine.